Checkpoint inhibition immunotherapy is beneficial for melanoma patients with brain metastases

被引：0
|
作者：
不详
机构：
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2018年 / 14卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：2099 / 2099
页数：1
相关论文
共 50 条
  • [21] Improvement in survival for melanoma patients with brain metastases treated with stereotactic radiosurgery and immunotherapy
    Slevin, Finbar
    Marples, Maria
    Hatfield, Paul
    CLINICAL ONCOLOGY, 2018, 30 : E2 - E2
  • [22] Radiotherapy and immunotherapy: Can this combination change the prognosis of patients with melanoma brain metastases?
    Franceschini, D.
    Franzese, C.
    Navarria, P.
    Ascolese, A. M.
    De Rose, F.
    Del Vecchio, M.
    Santoro, A.
    Scorsetti, M.
    CANCER TREATMENT REVIEWS, 2016, 50 : 1 - 8
  • [23] Can Immunotherapy Replace Radiotherapy in Melanoma Brain Metastases?
    Shinde, Ashwin
    Li, Richard
    Amini, Arya
    Glaser, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (12) : 1030 - +
  • [24] Melanoma with brain metastases: Experience of immunotherapy in a single center
    Naskhletashvili, D. R.
    Demidov, L. V.
    Bekyashev, A. H.
    Aloshin, V. A.
    Prozorenko, E. V.
    ANNALS OF ONCOLOGY, 2018, 29 : 130 - 130
  • [25] Radiosurgery/Stereotacticradiotherapy with Cyberknife and immunotherapy in melanoma brain metastases
    Borzillo, V.
    Di Franco, R.
    Falivene, S.
    Totaro, G.
    Ravo, V.
    Ascierto, P. A.
    Grimaldi, A. M.
    Cammarota, F.
    Muto, P.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S651 - S651
  • [26] Immune Checkpoint Inhibition and the Risk of Radionecrosis in Patients Treated with SRS for Brain Metastases
    Kowalski, E. S.
    Remick, J.
    Khairnar, R.
    Morse, E.
    Poirier, Y.
    Lamichhane, N.
    Becker, S. J.
    Mishra, M. V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E113 - E113
  • [27] DISTANT BRAIN FAILURE AND SALVAGE FREE SURVIVAL FOR RADIOSURGERY-TREATED MELANOMA BRAIN METASTASES IN THE ERA OF CHECKPOINT INHIBITOR IMMUNOTHERAPY
    Nguyen, Steven
    Keller, Andrew
    Pearson, Luke
    All, Sean
    Patel, Hanisha
    Ramakrishna, Naren
    NEURO-ONCOLOGY, 2018, 20 : 54 - 55
  • [28] A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors
    van Not, Olivier J.
    Wind, Thijs T.
    Ismail, Rawa K.
    Bhattacharya, Arkajyoti
    Jalving, Mathilde
    Blank, Christian U.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette W. P. J.
    Boers-Sonderen, Marye J.
    van den Eertwegh, Alfonsus J. M.
    de Groot, Jan Willem B.
    Haanen, John B.
    Kapiteijn, Ellen
    Bloem, Manja
    Piersma, Djura
    van Rijn, Rozemarijn S.
    Stevense-den Boer, Marion
    van der Veldt, Astrid A. M.
    Vreugdenhil, Gerard
    Wouters, Michel W. J. M.
    Blokx, Willeke A. M.
    Suijkerbuijk, Karijn P. M.
    Fehrmann, Rudolf S. N.
    Hospers, Geke A. P.
    CANCERS, 2023, 15 (11)
  • [29] Longitudinal Monitoring of ctDNA in Patients with Melanoma and Brain Metastases Treated with Immune Checkpoint Inhibitors
    Lee, Jenny H.
    Menzies, Alexander M.
    Carlino, Matteo S.
    McEvoy, Ashleigh C.
    Sandhu, Shahneen
    Weppler, Alison M.
    Diefenbach, Russell J.
    Dawson, Sarah-Jane
    Kefford, Richard F.
    Millward, Michael J.
    Al-Ogaili, Zeyad
    Tra, Thien
    Gray, Elin S.
    Wong, Stephen Q.
    Scolyer, Richard A.
    Long, Georgina, V
    Rizos, Helen
    CLINICAL CANCER RESEARCH, 2020, 26 (15) : 4064 - 4071
  • [30] Management of Brain Metastases in the New Era of Checkpoint Inhibition
    Adam Lauko
    Bicky Thapa
    Vyshak Alva Venur
    Manmeet S. Ahluwalia
    Current Neurology and Neuroscience Reports, 2018, 18
12345